ZYUS Life Sciences has acquired 1 company.
ZYUS Life Sciences’ largest acquisition to date was in 2019, when it acquired Ehave - Proprietary Health Informatics Platform for $2M. The Company’s most targeted sectors include medical products (100%).
204-407 Downey Road,
Saskatoon, Saskatchewan
S7N 4L8
Canada,
www.zyus.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-03-25 |
Ehave, Inc. - Proprietary Health Informatics Platform · Medical Products
Oakville, Ontario Ehave, Inc. - Proprietary Health Informatics Platform is a platform that contains components specifically designed to be used by medical cannabis patients to efficiently gather and verify patient-reported outcomes and experiences, evaluate treatment progress, enhance patient engagement and improve data modeling. |
2 | Divestiture |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
